SFERANGS COLLAGEN SYNERGY AMPOULE

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: SFERANGS COLLAGEN SYNERGY AMPOULE
Generic name: ADENOSINE
Manufacturer: NOKSIBCHO cosmetic Co., Ltd.
Product type: HUMAN OTC DRUG
SPL set ID: a22c5134-d8b1-a185-e053-2995a90ae0f0
SPL ID: a22c5ad3-9911-45df-e053-2995a90a2d13
Version: 1
Effective date: 2020-03-31
Source export date: 2026-09-28
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:00:55

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		SFERANGS COLLAGEN SYNERGY AMPOULE	openfda.brand_name
generic name		ADENOSINE	openfda.generic_name
manufacturer name		NOKSIBCHO cosmetic Co., Ltd.	openfda.manufacturer_name
ndc	package	73590-0040-1	openfda.package_ndc
ndc	product	73590-0040	openfda.product_ndc
ndc11	package	73590004001	derived:openfda.package_ndc
spl id		a22c5ad3-9911-45df-e053-2995a90a2d13	id
spl set id		a22c5134-d8b1-a185-e053-2995a90ae0f0	set_id
unii		K72T3FS567	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only When using this product ■ if the following symptoms occurs after use, stop use and consult with a skin specialist red specks, swelling, itching ■ don’t use on the part where there is injury, eczema, or dermatitis Keep out of reach of children ■ if swallowed, get medical help or contact a person control center immediately

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.